The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Active Motif sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Active Motif Inc (Active Motif) is a is biotechnology company using transposase technologies to simplify gene regulation, chromatin remodelling, DNA methylation, chromatin interrogation and histone modifications. Its products include kits for chIP Assay, chromatin Analysis, gene regulation and spike-in normalization. It also includes antibodies, recombinant proteins and enzymes, RAS GTPase products, sonication products and SARS-CoV-2 products and kits. Active Motif offers services like chIP-sequencing, CUT and Tag-IT, ChIC /CUT and RUN, Hi-C Service and others. The company has its operations in Belgium, Japan, the US, and China. Active Motif is headquartered in Carlsbad, California, the US. Key subsidiaries of Active Motif include Amaryllis Nucleics and Active Motif Chromeon.
The key metrics of Active Motif related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Active Motif is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Active Motif.
For a detailed understanding of the performance of Active Motif, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
